Connect Biopharma Holdings Ltd. (CNTB) Prices 11.25M ADS IPO at $17/ADS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/29/2026
- S&P 500 flat as higher bond yields counter tech optimism
- Anthropic prospectus shows $2T IPO ambition, warns of AI 'existential risk'
- Risk appetite remains concentrated in large-cap stocks, Citi says
- Netflix stock: Deutsche Bank gets bullish as valuation leaves room to run
- CarMax shares rise over 2% on strong earnings and revenue beat
- Workday cuts 2.5% of workforce, revises GAAP margin outlook
- Bloom Energy shares fall on Oracle project halt
- Exclusive-Activist Jana pushes Fiserv to accelerate cost cuts and tap Palantir
- Stocks fall as higher oil prices, Treasury yields weigh
- Oppenheimer sees AI software winners as focus shifts to ROI
Connect Biopharma Holdings Limited announces pricing of Initial Public Offering
March 18, 2021 11:58 PM EDTSAN DIEGO and TAICANG, China, March 18, 2021 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (the Company), a global clinical-stage biopharmaceutical company dedicated to improving the lives of patients with chronic inflammatory diseases through the development of therapies derived from T-cell-driven research, today announced the pricing of its initial public offering of 11,250,000 American Depositary Shares (ADSs), representing 11,250,000 ordinary shares of the Company, at a public offering price of US$17.00 per ADS.
All of the ADSs are being offered by the Company. The Company has granted the underwriters an option to purchase up to an additional 1,687,500 ADSs within 30 days from... More
